With many different pharmaceutical markets varying across the globe, and most market access professionals focusing on specific regions or therapeutic areas, we thought it best to provide an overview of the Global Reimbursement Trends to ensure you stay abreast of what is happening outside the confines of your Office Door |Department | Blackberry | Building Entrance (delete as [...]
Leading academics and practitioners from around the world offer their perspectives on HTA in their country and identify lessons learned.
I have had some real trouble embedding this due to TEDs uber-complex coding so here is the link the video. It is almost 15 minutes long, if you haven’t got time to watch it all now, save it for later.
The EuroQol Group has continued to invest in an ambitious research programme to develop a more refined version of EQ-5D for describing and valuing health: the EQ-5D-5L. The purpose of this symposium is to describe the process of development, to report the first experiences in patients and to explain the new software for eliciting valuations [...]
While the decline in the growth of national health care spending has largely been attributed to the recession, the changing behaviors of consumers and providers may also be a factor. As a share of the economy, health expenditures remained steady from 2009 to 2010.Original Source
(Reuters Health) – In an analysis of over 40,000 clinical trials registered in a government database, researchers found that many of those studies — looking at the effects of drugs, devices or behavioral interventions — were small and of inconsistent quality. Those are the studies doctor groups rely on when it comes to setting guidelines [...]
 |
 |
 |
 |
 |
